Search

everythinglearnresearchcommunity

for

Search:↓

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

New therapies for rare skin diseases show promise but need more research.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Upadacitinib improved multiple immune-related conditions in one patient.

PCOS diagnosis and management have improved with new guidelines for personalized care.

Experts created guidelines to better diagnose and treat uncommon fungal skin infections.

Mesotherapy might help with hair growth in androgenic alopecia, but more research is needed.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

The new microneedle system improves hair growth in alopecia treatment.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Exosomes show promise for skin treatments but need more research and regulation in India.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

The formulation helps improve wound healing and skin repair.

Early diagnosis and treatment of tinea capitis in children is crucial to prevent permanent hair loss and scarring.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

ARWH is a rare hair disorder with no cure, but potential treatments include minoxidil and other therapies.

Limelight (CB-EVs) safely promotes hair growth.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

Pharmacists play a crucial role in health literacy and patient care.

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Targeting specific cell interactions may help treat skin fibrosis.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.